RAP 3.57% 14.5¢ resapp health limited

Ann: ResApp Provides SMARTCOUGH-C-2 Study Update, page-59

  1. 49 Posts.
    lightbulb Created with Sketch. 2
    I've cared to do my research, however, it is clear that you haven't.

    Alcidion makes no reference to Mr Buzza on their website under management or board members tabs.

    https://www.alcidion.com.au/board-members/ & https://www.alcidion.com.au/management-team/

    Furthermore, Mr Buzza's LinkedIn page has his directorship with Alcidion ending in December 2017

    https://au.linkedin.com/in/nathanbuzza

    Per the company's announcement of his appointment dated 29 December 2017, his directorship is past tense;

    "More recently, Mr Buzza was an Executive Director of Alcidion Group Limited (ASX: ALC), a provider of clinical decision support systems. “I am privileged to be joining the board at such a pivotal moment in the Company’s history and help build upon the outstanding foundations that have already been laid,” said Mr Buzza"

    This wasn't an attack on your post, I was clearly just stating that in my opinion much of the requirements of the position could/should be handled by the current management and/or new member of the BOD.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.